Island Pharmaceuticals Limited (ILA.AX)
AUD 0.18
(2.94%)
AUD 0.18
(2.94%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.25 Million | 11.06 Thousand | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 1.25 Million | 11.06 Thousand | - | - | - | - |
| Operating Expenses | 4.12 Million | 2.9 Million | 2.8 Million | 2.13 Million | 658.00 | 430 Thousand |
| Selling, General and Administrative Expenses | 1.44 Million | 1.76 Million | 1.59 Million | 1.9 Million | 658.00 | 304 Thousand |
| Research and Development Expenses | 2.27 Million | 1.14 Million | 1.02 Million | 2588.00 | - | 126 Thousand |
| Other Expenses | - | 75.61 Thousand | 202.11 Thousand | 12.18 Thousand | - | - |
| Cost and Expenses | 4.12 Million | 2.9 Million | 2.8 Million | 2.13 Million | 658.00 | 430 Thousand |
| Operating Income | -2.87 Million | -2.9 Million | -2.8 Million | -2.13 Million | -658.00 | -430 Thousand |
| Interest Expense | 46.2 Thousand | 9000.00 | - | - | - | - |
| Income Tax Expense | - | -2.89 Million | -2.8 Million | -2.13 Million | - | - |
| Earnings before Tax | -2.86 Million | -2.83 Million | -2.6 Million | -2.12 Million | -658.00 | -430 Thousand |
| Net Income | -2.86 Million | -2.83 Million | -2.6 Million | -2.12 Million | -658.00 | -430 Thousand |
| Earnings Per Share Basic | -0.03 | -0.03 | -0.03 | -0.02 | - | - |
| Earnings Per Share Diluted | -0.03 | -0.03 | -0.03 | -0.02 | - | - |
| Weighted Average Shares Outstanding | 90.29 Million | 87.51 Million | 87.51 Million | 87.19 Million | - | - |
| Weighted Average Shares Outstanding (Diluted) | 90.29 Million | 87.51 Million | 87.51 Million | 87.19 Million | - | - |
| Gross Margin | 1.00 | 1.00 | - | - | - | - |
| EBIT Margin | -2.25 | -262.82 | - | - | - | - |
| Profit Margin | -2.29 | -255.80 | - | - | - | - |
| EBITDA | -2.81 Million | - | - | - | - | - |
| Earnings Before Tax Margin | -2.30 | -262.82 | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 151.26 Thousand | - | 151.26 Thousand | 474.52 Thousand | 474.52 Thousand | 11.06 Thousand |
| Cost of Revenue | 495.88 Thousand | - | 495.88 Thousand | 640.39 Thousand | 640.39 Thousand | - |
| Gross Profit | -344.62 Thousand | - | -344.62 Thousand | -165.87 Thousand | -165.87 Thousand | 11.06 Thousand |
| Operating Expenses | 996.9 Thousand | 4.12 Million | 996.9 Thousand | 2.13 Million | 407.12 Thousand | 2.9 Million |
| Selling, General and Administrative Expenses | 501.01 Thousand | - | 501.01 Thousand | 850.76 Thousand | 425.38 Thousand | - |
| Research and Development Expenses | 495.88 Thousand | - | 495.88 Thousand | 1.28 Million | 640.39 Thousand | - |
| Other Expenses | - | - | - | - | - | 75.61 Thousand |
| Cost and Expenses | 1.49 Million | 4.12 Million | 1.49 Million | 2.13 Million | 1.04 Million | 2.9 Million |
| Operating Income | -1.34 Million | -4.12 Million | -1.34 Million | -2.13 Million | -586.25 Thousand | -2.9 Million |
| Interest Expense | 33.34 Thousand | 46.2 Thousand | - | 12.85 Thousand | - | 9000.00 |
| Income Tax Expense | -302.52 Thousand | -1.25 Million | - | -386.34 Thousand | 8715.00 | -2.89 Million |
| Earnings before Tax | -854.62 Thousand | -4.11 Million | -854.62 Thousand | -1.54 Million | -577.53 Thousand | -2.83 Million |
| Net Income | -854.62 Thousand | -2.86 Million | -854.62 Thousand | -1.15 Million | -577.53 Thousand | -2.83 Million |
| Earnings Per Share Basic | -0.01 | - | -0.01 | -0.01 | -0.01 | - |
| Earnings Per Share Diluted | -0.01 | - | -0.01 | -0.01 | -0.01 | - |
| Weighted Average Shares Outstanding | 99.32 Million | 90.29 Million | 99.32 Million | 87.51 Million | 81.27 Million | 87.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.32 Million | 90.29 Million | 99.32 Million | 87.51 Million | 81.26 Million | 87.51 Million |
| Gross Margin | -2.28 | - | -2.28 | -0.35 | -0.35 | 1.00 |
| EBIT Margin | -13.18 | - | -3.28 | -4.49 | 0.02 | - |
| Profit Margin | -5.65 | - | -5.65 | -2.43 | -1.22 | -255.80 |
| EBITDA | -1.99 Million | - | -495.88 Thousand | -2.13 Million | 8715.00 | - |
| Earnings Before Tax Margin | -8.87 | - | -8.87 | -4.49 | -1.24 | -262.82 |
688798
BHARTIHEXA
0579
LTA
NEOINFRA
UD